Dr. Haytham Adada, MD

NPI: 1336324896
Total Payments
$10,638
2024 Payments
$6,273
Companies
33
Transactions
246
Medicare Patients
2,240
Medicare Billing
$351,026

Payment Breakdown by Category

Education$6,046 (56.8%)
Food & Beverage$4,586 (43.1%)
Travel$6.00 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Education $6,046 6 56.8%
Food and Beverage $4,586 239 43.1%
Travel and Lodging $6.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
INTUITIVE SURGICAL, INC. $6,214 7 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,480 65 $0 (2023)
GlaxoSmithKline, LLC. $344.61 22 $0 (2023)
Janssen Pharmaceuticals, Inc $319.27 21 $0 (2024)
Mallinckrodt Hospital Products Inc. $313.91 16 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $245.54 15 $0 (2019)
Genentech USA, Inc. $245.08 17 $0 (2019)
Novartis Pharmaceuticals Corporation $228.55 11 $0 (2019)
Merck Sharp & Dohme LLC $193.87 12 $0 (2022)
Covidien LP $131.35 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,273 11 INTUITIVE SURGICAL, INC. ($6,143)
2023 $524.46 20 AstraZeneca Pharmaceuticals LP ($352.62)
2022 $550.96 25 AstraZeneca Pharmaceuticals LP ($228.49)
2021 $515.82 33 AstraZeneca Pharmaceuticals LP ($148.93)
2020 $419.52 27 AstraZeneca Pharmaceuticals LP ($135.47)
2019 $1,049 47 AstraZeneca Pharmaceuticals LP ($310.78)
2018 $839.09 49 AstraZeneca Pharmaceuticals LP ($232.43)
2017 $466.66 34 Genentech USA, Inc. ($93.21)

All Payment Transactions

246 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/10/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $17.69 General
Category: Respiratory
12/03/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $103.63 General
Category: SURGERY
07/18/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.70 General
Category: Cardiovascular & Metabolism
06/27/2024 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $26.14 General
Category: EMERGENT HYPOTENSION
05/28/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $39.56 General
Category: SURGERY
05/13/2024 La Jolla Pharmaceutical Company GIAPREZA (Drug) Food and Beverage In-kind items and services $16.15 General
Category: EMERGENT HYPOTENSION
04/11/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $18.07 General
Category: CRITICAL CARE
04/02/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $18.40 General
Category: INFLAMMATION AND IMMUNOLOGY
03/14/2024 ABBVIE INC. AVYCAZ (Drug), TEFLARO Food and Beverage In-kind items and services $17.33 General
Category: ANTI-INFECTIVE
02/09/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education In-kind items and services $3,000.00 General
Category: SURGERY
02/02/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Education In-kind items and services $3,000.00 General
Category: SURGERY
12/05/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $16.99 General
Category: SURGERY
12/02/2023 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $27.73 General
Category: IMMUNOLOGY
10/24/2023 Intuitive Surgical, Inc. Da Vinci Surgical System (Device) Travel and Lodging In-kind items and services $6.00 General
Category: SURGERY
09/26/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $15.86 General
Category: Respiratory
09/18/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $15.50 General
Category: Cardiovascular & Metabolism
08/24/2023 AstraZeneca Pharmaceuticals LP TEZSPIRE (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Respiratory
08/22/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.82 General
Category: Cardiovascular & Metabolism
08/17/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $15.26 General
Category: Respiratory
08/17/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.36 General
Category: Respiratory
06/28/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Education In-kind items and services $11.56 General
Category: Respiratory
06/22/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $14.96 General
Category: Respiratory
06/13/2023 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $16.30 General
Category: RESPIRATORY
06/01/2023 Takeda Pharmaceuticals U.S.A., Inc. ARALAST (Biological) Food and Beverage In-kind items and services $14.69 General
Category: IMMUNOLOGY
05/31/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $20.38 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 556 846 $261,516 $85,320
2022 15 548 850 $243,697 $86,789
2021 15 527 857 $247,817 $90,991
2020 15 609 896 $252,856 $87,926
Total Patients
2,240
Total Services
3,449
Medicare Billing
$351,026
Procedure Codes
62

All Medicare Procedures & Services

62 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 58 215 $103,251 $34,860 33.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 46 85 $20,330 $7,808 38.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 53 99 $16,000 $6,103 38.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 38 62 $17,076 $6,071 35.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 58 70 $13,510 $4,631 34.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 32 32 $13,318 $4,350 32.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 34 34 $12,470 $3,949 31.7%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2023 21 24 $7,200 $2,569 35.7%
31629 Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope Facility 2023 17 17 $6,975 $2,384 34.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 23 23 $6,671 $2,359 35.4%
31652 Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes Facility 2023 16 16 $7,708 $2,310 30.0%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 48 50 $14,570 $2,176 14.9%
36556 Insertion of non-tunneled central venous tube for infusion (5 years or older) Facility 2023 27 29 $5,399 $1,859 34.4%
31627 Computer-assisted image-guided navigation of lung airways using an endoscope Facility 2023 20 20 $4,237 $1,489 35.1%
31628 Biopsy of lobe of lung using an endoscope, 1 lobe Facility 2023 26 26 $10,055 $1,433 14.3%
31654 Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound Facility 2023 12 12 $1,768 $620.04 35.1%
76937 Ultrasonic guidance for blood vessel access Facility 2023 27 32 $978.00 $346.54 35.4%
99291 Critical care, first 30-74 minutes Facility 2022 70 221 $100,560 $37,291 37.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 56 117 $24,936 $9,305 37.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 64 124 $18,386 $6,951 37.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 67 79 $14,857 $5,665 38.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 34 35 $14,303 $5,146 36.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 37 39 $10,885 $4,084 37.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 31 31 $10,777 $3,826 35.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 33 40 $10,634 $3,719 35.0%

About Dr. Haytham Adada, MD

Dr. Haytham Adada, MD is a Internal Medicine healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1336324896.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haytham Adada, MD has received a total of $10,638 in payments from pharmaceutical and medical device companies, with $6,273 received in 2024. These payments were reported across 246 transactions from 33 companies. The most common payment nature is "Education" ($6,046).

As a Medicare-enrolled provider, Adada has provided services to 2,240 Medicare beneficiaries, totaling 3,449 services with total Medicare billing of $351,026. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Critical Care Medicine, Internal Medicine
  • Location Abingdon, VA
  • Active Since 01/03/2008
  • Last Updated 05/15/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1336324896

Products in Payments

  • Da Vinci Surgical System (Device) $6,214
  • FASENRA (Drug) $518.23
  • FASENRA (Biological) $386.18
  • XARELTO (Drug) $319.27
  • TEZSPIRE (Biological) $282.99
  • ACTHAR (Biological) $261.07
  • LifeVest (Device) $245.54
  • ENTRESTO (Drug) $228.55
  • NUCALA (Biological) $215.32
  • ZERBAXA (Drug) $175.89
  • Xolair (Biological) $168.31
  • TRELEGY ELLIPTA (Drug) $129.29
  • SYMBICORT (Drug) $125.72
  • ELIQUIS (Drug) $116.57
  • superDimension (Device) $97.08
  • Esbriet (Biological) $76.77
  • Yupelri (Drug) $76.41
  • Impella (Device) $58.74
  • Veltassa (Drug) $55.78
  • Corlanor (Drug) $52.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Abingdon